If you assumed FDA inspections would eventually go back to the way they were before COVID, think again. The shift toward hybrid and remote inspections that started during the pandemic has become a permanent part of how the FDA conducts oversight - and it's having a bigger impact on warning letters than most organizations anticipated. In FY2024, remote information requests or failures to respond to them accounted for nearly a quarter of all warning letters issued by the FDA. T